Lessee, Operating Lease, Liability, to be Paid, Year One of LakeShore Biopharma Co., Ltd. from 31 Mar 2023 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD and CNY
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
LakeShore Biopharma Co., Ltd. quarterly Lessee, Operating Lease, Liability, to be Paid, Year One in USD history and change rate from 31 Mar 2023 to 31 Mar 2025.
  • LakeShore Biopharma Co., Ltd. Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending 31 Mar 2025 was $65,521, a 91% decline year-over-year.
LakeShore Biopharma Co., Ltd. quarterly Lessee, Operating Lease, Liability, to be Paid, Year One in CNY history and change rate from 31 Mar 2023 to 31 Mar 2025.
  • LakeShore Biopharma Co., Ltd. Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending 31 Mar 2025 was ¥470,319, a 91% decline year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Change (%)
Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (CNY)
Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Change (%)

LakeShore Biopharma Co., Ltd. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year One (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $65,521 -$693,653 -91% 31 Mar 2025 20-F 31 Jul 2025 2025 FY
Q1 2024 $759,174 +$5,504 +0.73% 31 Mar 2024 20-F 15 Aug 2024 2024 FY
Q1 2023 $753,670 31 Mar 2023 20-F 26 Jul 2023 2023 FY

LakeShore Biopharma Co., Ltd. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year One (CNY)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 ¥470,319 -¥4,916,021 -91% 31 Mar 2025 20-F 31 Jul 2025 2025 FY
Q1 2024 ¥5,386,340 +¥207,347 +4% 31 Mar 2024 20-F 15 Aug 2024 2024 FY
Q1 2023 ¥5,178,993 31 Mar 2023 20-F 26 Jul 2023 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.